MiNK Therapeutics INKT is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that MiNK Therapeutics will report an earnings per share (EPS) of $-0.08.
The announcement from MiNK Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
In the previous earnings release, the company beat EPS by $0.03, leading to a 1.01% drop in the share price the following trading session.
Here's a look at MiNK Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.15 | -0.15 | -0.18 |
| EPS Actual | -0.07 | -0.11 | -0.16 | -0.15 |
| Price Change % | -1.0% | -7.000000000000001% | -2.0% | -5.0% |
Performance of MiNK Therapeutics Shares
Shares of MiNK Therapeutics were trading at $0.78 as of November 12. Over the last 52-week period, shares are down 21.52%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for MiNK Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
